Cite
HARVARD Citation
Ndiaye, B. et al. (2015). Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial. Lancet. 3 (3), pp. 190-200. [Online].